Clonidine is an α 2 adrenoceptor agonist that is frequently used to reduce withdrawal symptoms during opioid detoxification in humans. The long-term effects of clonidine on withdrawal symptoms and its ...

Length of treatment and neurobehavioral scores did not significantly differ between infants with prenatal opioid exposure randomized to either clonidine or morphine, researchers found. Among infants ...

Previous pharmacological studies have implicated serotonergic brain systems in opiate-withdrawal-precipitated conditioned place aversion. To assess this hypothesis, we tested the effects of either (i) ...

A randomized clinical trial compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential ...

Objective: To evaluate literature reporting on the role of norepinephrine in alcohol withdrawal and to determine the safety and efficacy of α 2-agonists in reducing symptoms of this severe condition.

The data showed patients receiving buprenorphine (90.3%) were significantly more likely to be retained at the end of the taper vs. patients receiving clonidine (66.1%) but retention with tramadol ER ...

The extended-release formulation of the mild opiate tramadol may keep patients in "detox" and suppress withdrawal symptoms, researchers found. In a randomized controlled trial, more participants ...

It’s not only people addicted to alcohol or drugs who experience significant withdrawal symptoms if they stop using. Antidepressant (AD) withdrawal symptoms are also common, can be severe and ...

Extended-release formulations of tramadol hydrochloride (tramadol ER) (multiple brands) may provide an alternative treatment option for reducing withdrawal symptoms in patients with opioid use ...